24.4 C
New York
Friday, June 12, 2026

Tag: Daewoong Pharmaceutical Co.

newssourceFORcompanyinformationcontent1marketreleases

Daewoong Therapeutics Microneedle Patch Achieves Best-in-Class Bioavailability, Proving the Strength of Its Drug-Delivery Platform

More than 80% relative bioavailability compared with injectable obesity therapy, well above the roughly 30% reported for existing microneedle patches and setting a new...

Daewoong Pharmaceutical Launches NABOTA in Qatar, Expands Presence in High-Potential GCC Aesthetic Market

DOHA, Qatar, June 12, 2025  /PRNewswire/ -- Daewoong Pharmaceutical has officially launched its high-purity, high-quality botulinum toxin, NABOTA, in Qatar—further reinforcing its strategy to...

Salipro Biotech and Daewoong Pharmaceutical Announce Collaboration Agreement to Advance Development of Novel Therapeutics

- The collaboration combines Salipro Biotech's unique expertise and its Salipro® platform technology to stabilize a challenging drug target and advance Daewoong Pharmaceutical's drug...

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDaewoong Pharmaceutical Co.

Explore

Press Releases

News & Opinion

Living

Others

Follow us

© Copyright 2025. BusinessPressWire® / 14 Wall Street New York City NY 10005 +1 888-502-0266 / Disclaimers